BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35309942)

  • 21. Pyroptosis-Related Patterns Predict Tumor Immune Landscape and Immunotherapy Response in Bladder Cancer.
    Yan Y; Cao X; Wang Z; Huang Z; Cai J; Tang P; Yang C; Zhang F; Xia S; Shen B
    Front Mol Biosci; 2022; 9():815290. PubMed ID: 35558555
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of Novel Pyroptosis-Related lncRNAs Associated with the Prognosis of Breast Cancer Through Interactive Analysis.
    Gao L; Li Q
    Cancer Manag Res; 2021; 13():7175-7186. PubMed ID: 34552353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer.
    Zhang Y; Zhu B; He M; Cai Y; Ying X; Jiang C; Ji W; Zeng J
    Front Oncol; 2021; 11():710767. PubMed ID: 34458149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Breast Cancer.
    Wu J; Zhu Y; Luo M; Li L
    Front Immunol; 2021; 12():748221. PubMed ID: 34659246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
    Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S
    Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304
    [No Abstract]   [Full Text] [Related]  

  • 26. Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma.
    Liu ZK; Wu KF; Zhang RY; Kong LM; Shang RZ; Lv JJ; Li C; Lu M; Yong YL; Zhang C; Zheng NS; Li YH; Chen ZN; Bian H; Wei D
    Front Oncol; 2022; 12():794034. PubMed ID: 35311105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L; Xie R; Lu G
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive Analysis of the Immune-Oncology Targets and Immune Infiltrates of
    Zhang X; Shen L; Cai R; Yu X; Yang J; Wu X; Zhu Y; Liu X
    Front Cell Dev Biol; 2021; 9():686675. PubMed ID: 34277627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Pyroptosis-Related Subtypes
    Li C; Pan J; Jiang Y; Wu Y; Jin Z; Chen X
    Front Genet; 2022; 13():788670. PubMed ID: 35386285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of 5-inflammatory-gene signature to affect the immune status and predict prognosis in breast cancer.
    Zang H; Ni G; Gong L
    Cent Eur J Immunol; 2022; 47(3):218-233. PubMed ID: 36817270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyroptosis-Related Signatures for Predicting Prognosis in Breast Cancer.
    Ren T; Guo X; Zhang J; Liu Z
    Front Surg; 2022; 9():788437. PubMed ID: 35211500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
    Zhang X; Zhang M; Zhang X; Zhu X; Wang J
    BMC Med Inform Decis Mak; 2020 Jul; 20(Suppl 3):136. PubMed ID: 32646427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of an Aging-Related Gene Signature in Predicting Prognosis and Indicating Tumor Immune Microenvironment in Breast Cancer.
    Lv W; Zhao C; Tan Y; Hu W; Yu H; Zeng N; Zhang Q; Wu Y
    Front Oncol; 2021; 11():796555. PubMed ID: 34976839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering the Pyroptosis-Related Prognostic Signature and Immune Cell Infiltration Characteristics of Colon Cancer.
    Wei R; Li S; Yu G; Guan X; Liu H; Quan J; Jiang Z; Wang X
    Front Genet; 2021; 12():755384. PubMed ID: 34712271
    [No Abstract]   [Full Text] [Related]  

  • 35. Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma.
    Zhang S; Chen S; Wang Y; Zhan Y; Li J; Nong X; Gao B
    Front Genet; 2021; 12():744304. PubMed ID: 34976004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
    Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
    Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
    [No Abstract]   [Full Text] [Related]  

  • 38. Autophagy related long non-coding RNA and breast cancer prognosis analysis and prognostic risk model establishment.
    Luo Z; Nong B; Ma Y; Fang D
    Ann Transl Med; 2022 Jan; 10(2):58. PubMed ID: 35282059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma.
    Xing Z; Liu Z; Fu X; Zhou S; Liu L; Dang Q; Guo C; Ge X; Lu T; Zheng Y; Dai L; Han X; Wang X
    Front Cell Dev Biol; 2022; 10():805291. PubMed ID: 35223836
    [No Abstract]   [Full Text] [Related]  

  • 40. Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas.
    Zhou Z; Wei J; Lu B; Jiang W; Bao Y; Li L; Wang W
    Front Genet; 2021; 12():763807. PubMed ID: 35198000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.